Shortage of #SARSCoV2 monoclonal antibodies?
Only 30% of >550,000 doses distributed have been given to patients
https://khn.org/news/article/patients-fend-for-themselves-to-access-highly-touted-covid-antibody-treatments/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsmi=107323106&_hsenc=p2ANqtz--YhxuThcpwYZwtakmVxtCV2KoD1KPtTxi2BDOMJSSC3zekFiP9R4n0WpbGS6GkPLBivdY5bFLViDRlz4kedQcXI05GYA&utm_content=107323106&utm_source=hs_email … by @JoNel_Aleccia @KHNews
-
-
Probably VIPs getting their doses first.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
1) Logistics - Needs to given *before* hospital to be effective (ie as outpatient), 2) Messaging and med body clarity - med community, as whole, not capable of understanding ‘anti-virals’ need be given early so v confused by RCT results (hospital trials failed, outpatient great)
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@zeynep hy the time someone starts feeling symptoms, gets an appointment for a test, waits for the results of test, makes appointment to get in touch with doctor, it is often not soon enough to be effective. Need more awareness of treatment early in disease courseThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
A long list, including: Lack of infusion centers Lack of organization Lack of identifying high-risk before they present sick, for hospitalization (too late) Lack of belief by clinicians of benefit (no Phase 3 trials done)
-
The lack of meaningful clinical research is a national shame. The Recovery Trial shows what's possible and meaningful.
End of conversation
New conversation -
-
-
The main benefit comes if used at an early stage and it's hard to get people to go to infusion centers for multiple iv treatments when they are not yet showing severe symptoms.
-
I bet it wouldn't be if it were suggested and made easily available. And, I suppose, if people knew it wouldn't cost thousands of dollars.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.